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Closely related strains of Escherichia coli have been 
shown to cause extraintestinal infections in unrelated per-
sons. This study tests whether a food reservoir may exist 
for these E. coli. Isolates from 3 sources over the same time 
period (2005–2007) and geographic area were compared. 
The sources comprised prospectively collected E. coli iso-
lates from women with urinary tract infection (UTI) (n = 353); 
retail meat (n = 417); and restaurant/ready-to-eat foods (n 
= 74). E. coli were evaluated for antimicrobial drug suscep-
tibility and O:H serotype and compared by using 4 different 
genotyping methods. We identiﬁ   ed 17 clonal groups that 
contained E. coli isolates (n = 72) from >1 source. E. coli 
from retail chicken (O25:H4-ST131 and O114:H4-ST117) 
and honeydew melon (O2:H7-ST95) were indistinguish-
able from or closely related to E. coli from human UTIs. This 
study provides strong support for the role of food reservoirs 
or foodborne transmission in the dissemination of E. coli 
causing common community-acquired UTIs.
E
xtraintestinal infections caused by Escherichia coli 
cause serious illness and death. Every year, 6–8 mil-
lion cases of uncomplicated urinary tract infections (UTI) 
occur in the United States and 130–175 million cases oc-
cur globally; >80% are associated with E. coli (1,2). The 
urinary tract is the most common source for E. coli causing 
bloodstream infections, which cause 40,000 deaths from 
sepsis each year in the United States (1). Uncomplicated 
UTIs alone are responsible for an estimated $1–$2 billion 
of direct healthcare costs in the United States annually (1,2). 
Antimicrobial drug resistance among extraintestinal E. coli 
is further adding to the cost of treating these infections (3). 
Drug-resistant infections often require more complicated 
treatment regimens and result in more treatment failures.
The immediate reservoir of E. coli that causes extraint-
estinal infections is the intestinal tract of the person. Al-
though extraintestinal infections caused by E. coli are not 
usually associated with outbreaks, mounting evidence shows 
that extraintestinal E. coli may be responsible for commu-
nity-wide epidemics. For instance, in 2001, we reported the 
discovery of E. coli O11/O77/O17/O73:K52:H18-ST69. 
This clonal group caused 11% of all E. coli UTIs and 49% 
of all trimethoprim/sulfamethoxazole-resistant E. coli 
UTIs in 1 California community over a 4-month period (4). 
It caused antimicrobial drug–resistant UTIs in Michigan, 
Minnesota, and Colorado (5), and pyelonephritis in several 
states (6). Other outbreaks of UTIs caused by E. coli have 
been described, including a large E. coli O15:K52:H1 out-
break in South London (7), clusters of cases in Copenha-
gen, Denmark, caused by E. coli O78:H10 (8), and cases in 
Calgary, Alberta, Canada, caused by an extended-spectrum 
β-lactamase-producing E. coli (9).
Identiﬁ  cation of these outbreak strains has suggested 
that environmental sources, possibly contaminated meat 
and other foods, may play a role in the local spread of 
closely related E. coli strains. If there is a food animal reser-
voir for extraintestinal E. coli, then the use of antimicrobial 
agents in food animal production may select for antimicro-
bial drug–resistant forms of extraintestinal E. coli (10,11). 
Links between antimicrobial resistance and speciﬁ  c strains 
of extraintestinal E. coli in animal food products, speciﬁ  -
cally chicken meat, and human infections have been ob-
served (12–16). In a previous study, we noted an increase 
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in antimicrobial drug–resistant UTIs among women who 
report frequent chicken and pork consumption (17).
Evidence showing that food can be a reservoir for ex-
traintestinal E. coli includes 1) community-based outbreaks 
of extraintestinal infections caused by epidemic strains of E. 
coli causing uncomplicated UTIs (4,18) and other severe in-
fections (6,19,20); 2) the determination that these epidemic 
strains share antimicrobial drug susceptibility patterns and 
genotypes with isolates from retail meat (12–15); and 3) the 
epidemiologic association between retail meat consumption 
and intestinal acquisition of antimicrobial drug–resistant E. 
coli causing UTIs (17). On the basis of these observations, 
we hypothesize that retail chicken is the main reservoir for 
E. coli causing human extraintestinal infections. 
Methods
Study Design
E. coli isolates from human clinical samples, restau-
rant/ready-to-eat foods, and retail meat were systematically 
sampled over the same period. Human clinical isolates and 
restaurant/ready-to-eat isolates were obtained from Mon-
tréal, Québec, Canada. Retail meat isolates from Québec 
and Ontario were included because women with infections 
were primarily from these regions. We hoped to maximize 
the probability that matching genotypes between E. coli 
from these 3 sources could be identiﬁ  ed. E. coli isolates 
from each source were cultured and processed separately 
to prevent cross-contamination. The study protocol was 
approved by the McGill University Institutional Review 
Board (A01-M04-05A). 
Sampling of E. coli Causing Human UTIs
E. coli isolates from women with UTIs in Montréal 
from June 1, 2005, to May 30, 2007, were included. Wom-
en 18–45 years of age with a suspected UTI were enrolled. 
UTI was deﬁ  ned as the presence >2 relevant symptoms 
including dysuria, increased urinary frequency or urgen-
cy, pyuria, and hematuria and >102 colony-forming units 
of E. coli per milliliter of clean-catch urine (21). A total 
of 1,395 consecutive UTI samples were obtained. Details 
about specimen culture and bacterial identiﬁ  cation of E. 
coli are provided in Manges et al. (18). One E. coli isolate 
from each urine culture was arbitrarily selected for further 
analysis. If a woman had had recurrent UTIs, only the iso-
late from the ﬁ  rst infection was included. The study sample 
(n = 353) of E. coli isolates was assembled in the follow-
ing manner. All cephalothin-resistant E. coli (n = 19) were 
included. Isolates known to be members of a clonal group 
(n = 46) found to be closely related to or indistinguishable 
from other E. coli causing UTI in unrelated women were 
included (4,18,22) because we hypothesized that these 
E. coli would be more likely to be associated with food 
sources. A random sample of E. coli isolates resistant to >1 
antimicrobial agents was assembled (n = 172). We chose to 
oversample resistant E. coli, as antimicrobial resistance has 
been associated with possible outbreaks of extraintestinal 
E. coli infections. A random sample of fully susceptible E. 
coli isolates (n = 116) was selected. 
Sampling of E. coli from Retail Meat
A total of 417 E. coli isolates from fresh, raw retail 
chicken, beef, and pork products were selected from the 
collection of the Canadian Integrated Program for An-
timicrobial Resistance Surveillance (CIPARS), which 
monitors antimicrobial resistance in bacteria from meat 
obtained from grocery and other retail stores in sev-
eral provinces in Canada (23). Isolates collected by the 
CIPARS in Montréal, areas of Québec outside Montréal, 
and parts of Ontario from January 1, 2005, to July 31, 
2007, were included as follows. All CIPARS isolates 
from Montréal were included because all cases of UTI 
occurred in Montréal (n = 197). All CIPARS nalidixic 
acid–resistant E. coli from all regions of Canada were in-
cluded (n = 24); these isolates have been associated with 
reduced susceptibility to ﬂ  uoroquinolones.  Randomly 
selected susceptible and resistant isolates from outside 
Montréal, including other regions of Québec and Ontario, 
were selected to better represent the possible sources of 
retail meat exposure for the UTI cases. The overall sam-
pling fraction for retail chicken meat-associated isolates 
was ≈60%, given that our primary hypothesis focused on 
retail chicken meat. The sampling fraction for retail beef 
was 20% and for retail pork 20%. A strong association be-
tween extraintestinal E. coli clonal groups and antimicro-
bial resistance has been reported (4,7,9,18). Our targeted 
sampling fraction for antimicrobial resistance was 60% 
for each retail meat category; however, only 25% of retail 
beef isolates were resistant.
Sampling of E. coli from Restaurant/
Ready-to-Eat Food Sources
We included all 74 E. coli isolates from restaurant 
and ready-to-eat food sources for Montréal collected from 
January 1, 2005, to December 31, 2007, by the Division 
de l’Inspection des Aliments (24,25). These isolates were 
recovered from a range of prepared and ready-to-eat foods, 
including meat, fruit, vegetables, and other items. Isolates 
were collected as part of routine surveillance activities and 
from complaint-related inspections of restaurants and es-
tablishments offering ready-to-eat foods.
Antimicrobial Drug Susceptibility
We determined the minimum inhibitory concentration 
values for 15 antimicrobial agents for all E. coli isolates by 
the broth microdilution method (26), using the Sensititre 
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Automated Microbiology System (Trek Diagnostic Sys-
tems Ltd., Cleveland, OH, USA). National Antimicrobial 
Resistance Monitoring System (NARMS) susceptibility 
panel CMV1AGNF was used for E. coli testing. Human 
clinical and restaurant/ready-to-eat isolates were also eval-
uated for resistance to cephalothin and nitrofurantoin by a 
standard disk diffusion method (27). Isolates were deﬁ  ned 
as resistant, intermediate, or susceptible according to Clini-
cal and Laboratory Standards Institute and NARMS guide-
lines (23). Isolates exhibiting intermediate resistance were 
interpreted as susceptible.
Multilocus Variable Number Tandem Repeat Analysis
We performed multilocus variable number tandem re-
peat analysis (MLVA) on all isolates using capillary elec-
trophoresis methods as described previously in Manges 
et al. (28). Essentially, 8 loci were ampliﬁ  ed in separate 
PCRs by using ﬂ  uorescent primers. Raw fragment lengths 
for each locus were binned manually using a minimum 
threshold of ± 3 bp to distinguish alleles. E. coli CFT073, 
K12, and O157:H7 were used as positive controls. The 
set of 8 alleles for each isolate was deﬁ  ned as the MLVA 
proﬁ  le.
Enterobacterial Repetitive Intergenic 
Consensus Sequence 2 PCR Fingerprinting
E. coli isolates exhibiting indistinguishable MLVA 
proﬁ  les were compared by enterobacterial repetitive in-
tergenic consensus sequence 2 PCR (ERIC2 PCR) ﬁ  nger-
printing (29). Isolates with ﬁ  ngerprints that were indistin-
guishable on visual inspection were grouped and selected 
for further typing.
Clonal Group Deﬁ  nition
A clonal group was deﬁ  ned as >2 E. coli isolates ex-
hibiting indistinguishable MLVA and ERIC2 PCR patterns. 
We focused only on groups identiﬁ  ed by MLVA and ER-
IC2 PCR that contained members from >1 source. Groups 
containing isolates from retail meat and restaurant/ready-
to-eat food sources were included to determine whether re-
lated extraintestinal E. coli from retail meat isolates could 
be identiﬁ  ed in prepared food. These groups were given 
a designation that included the serogroup and multilocus 
sequence type (MLST), as in serogroup O25:H4 and ST131 
(O25:H4-ST131). Selected isolates representing each clon-
al group were chosen and evaluated by pulsed-ﬁ  eld gel 
electrophoresis (PFGE), serotyping, MLST, and phyloge-
netic typing to conﬁ  rm the identities of these clonal groups 
and to deﬁ  ne their within-group variability.
Pulsed-Field Gel Electrophoresis
The standard Centers for Disease Control and Preven-
tion protocol for molecular subtyping of E. coli O157:H7 
by PFGE was used (30). PFGE of XbaI- and NotI-digested 
DNA was performed on selected isolates belonging to each 
clonal group. Isolates exhibiting identical PFGE patterns 
were considered genetically indistinguishable, those exhib-
iting 1–3 band differences were considered closely related, 
and those exhibiting 4–6 band differences were considered 
possibly related (31).
Serotyping
The Public Health Agency of Canada Laboratory for 
Foodborne Zoonoses performed O- and H-serotyping us-
ing established protocols. Isolates that did not react with O 
antiserum were classiﬁ  ed as nontypeable (ONT), and those 
that were nonmotile were denoted NM.
MLST and Phylotyping
MLST on selected E. coli isolates was performed as 
previously described (32). Gene ampliﬁ  cation and sequenc-
ing were performed by using the primers speciﬁ  ed at the 
E. coli MLST website (http://mlst.ucc.ie/mlst/dbs/Ecoli). 
Allelic proﬁ  le and sequence type determinations were as-
signed according to this website’s scheme. Determination 
of the major E. coli phylogenetic groups (A, B1, B2, and D) 
was performed by multiplex PCR (33).
Statistical Analyses
Proportions and 95% conﬁ  dence intervals for propor-
tions were estimated. Differences in proportions were as-
sessed by χ2 tests; statistical signiﬁ  cance was deﬁ  ned as a p 
value <0.05. All analyses were conducted using Stata ver-
sion 9.0 (StataCorp LP, College Station, TX, USA).
Results
Final Sample Assembly
We analyzed 844 E. coli isolates obtained from human 
UTIs (n = 353), retail meat (n = 417), and restaurant/ready-
to-eat foods (n = 74). Table 1 contains details regarding the 
year of isolation, geographic location, and speciﬁ  c meat or 
food source.
Clonal Group Identiﬁ  cation and Characterization
Seventeen clonal groups were identiﬁ  ed (containing 
a total of 72 isolates). Eleven groups contained isolates 
from human infections and retail meat sources; 5 groups 
contained isolates from retail meat and restaurant/ready-
to-eat food sources; and 1 group contained isolates from 
restaurant/ready-to-eat food and human infections. Fifty-
seven representative isolates were selected for evaluation 
by PFGE, MLST, serotyping, and phylotyping (Table 2).
On the basis of PFGE patterns, we identiﬁ  ed 2 clonal 
groups (group 1 and group 2) that contained genetically 
indistinguishable isolates and 1 clonal group (group 3) 
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that contained closely related isolates from food sources 
and human UTIs. Group 1 contained E. coli characterized 
as O25:H4-ST131, which was identiﬁ  ed in 1 sample of 
retail chicken meat and in 2 cases of human infection. The 
XbaI PFGE patterns of the human isolate (MSHS 161) 
and the retail chicken isolate (EC01DT06-1737-01) were 
indistinguishable, and the second human isolate (MSHS 
1134A) differed by 1 band from the other 2 patterns (Fig-
ure 1, panel A). The NotI PFGE patterns of the 2 human 
isolates, which were indistinguishable, differed from the 
retail chicken isolate by a single band (Figure 1, panel B). 
The retail meat isolate from this group was susceptible 
to all antimicrobial agents tested, while 1 of the 2 iso-
lates from human infections was resistant to cephalothin 
and the second was resistant to ampicillin, streptomycin, 
sulﬁ  soxazole, and tetracycline.
Group 2 contained E. coli characterized as O2:H7-
ST95; one isolate was from a restaurant/ready-to-eat food 
source (a honeydew melon) and 8 isolates were from cases 
of human infection. The XbaI PFGE patterns were indistin-
guishable for 3 of the human infection isolates (MSHS 100, 
186, and 811) and the restaurant/ready-to-eat food isolate 
(68616.01); the other 5 O2:H7-ST95 isolates differed by 
1 band (MSHS 1229), two bands (MSHS 95 and MSHS 
1062), and 4 bands (MSHS 782 and MSHS 819) from the 
food source isolate, respectively (Figure 1, panel A ). The 
NotI PFGE patterns for MSHS 100 and MSHS 186 were 
indistinguishable from the restaurant/ready-to-eat isolate, 
and the other human infection isolates differed by 1 to 7 
bands (Figure 1, panel B). The E. coli isolate from the food 
source was fully susceptible, as were most isolates from 
the human infections, except for 2 (one was resistant to 
ampicillin, and the second to ampicillin, sulﬁ  soxazole, and 
trimethoprim/sulfamethoxazole).
Group 3 contained E. coli characterized as O114:H4-
ST117; one isolate was from retail chicken meat and the 
second was from a human UTI. The XbaI PFGE patterns 
of the human infection isolate (MSHS 1014A) and retail 
meat isolate (EC01DT05-0789-01) differed by 5 bands 
(Figure 2). The NotI PFGE patterns differed by >6 bands 
(Figure 2). Both isolates were fully susceptible. In addition 
to shared PFGE patterns, these 3 groups of E. coli shared 
the same MLSTs, serotypes, and phylotypes.
The clonal group characterized as E. coli O17/O73/
O77:H18-ST69, also known as clonal group A (4), was 
identiﬁ   ed in human and retail meat samples, although 
closely related PFGE patterns were not observed (group 4, 
Table 2). Three other groups (groups 5–7, Table 2), char-
acterized as E. coli O4:H5-ST493, O36:NM-ST401, and 
O172:H16-ST295, exhibited shared MLSTs, serotypes, 
and phylotypes, but the PFGE patterns were not related. 
Discussion
We report the identiﬁ  cation of E. coli isolates from re-
tail chicken and other food sources that are indistinguish-
able from or closely related to isolates from human UTIs. 
Our a priori hypothesis, based on results from previous 
studies, suggests that retail meat, speciﬁ  cally retail chicken 
meat, could be a reservoir for E. coli causing human ex-
traintestinal infections. This study provides strong support 
for this hypothesis on the basis of genetic similarities be-
tween food and human clinical isolates.
Johnson et al. have proposed that antimicrobial drug–
resistant E. coli from human feces (and human bloodstream 
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Table 1. Sources of 844 Escherichia coli isolates collected and analyzed in Canada, by year and location, 2005–2007* 
Year, no. (%) isolates  Location, no. (%) isolates 
Source
Total no. (%) 
isolates 2005  2006   2007  Quebec Ontario Other† 
Clinical
  UTI  353 (42)  103 (29)  175 (50)  75 (21)  353 (100)  0 0
Retail meat 
  All  417 (49)  178 (43)  158 (38)  81(19) 264 (63)  139 (33)  14 (3) 
    Chicken  253 (61)  107 (42)  101 (40)  45 (18)  141 (56)  99 (39)  13 (5) 
    Beef  82 (20)  37 (45)  26 (32)  19 (23)  81 (99)  1 (1)  0
    Pork  82 (20)  34 (41)  31 (38) 17 (21)  42 (51)  39 (48)  1 (1) 
Restaurant/ready-to-eat foods 
  All  74 (9)  19 (26)  33 (45)  22 (30)  74 (100)  0 0
    Chicken  21 (28)  7 (33)  6 (29)  8 (38)  21 (100)  0 0
    Beef  13 (18)  3 (23)  6 (46)  4 (31)  13 (100)  0 0
    Pork  5 (7)  0 4 (80)  1 (20)  5 (100)  0 0
    Fish/seafood  6 (8)  2 (33)  2 (33)  2 (33)  6 (100)  0 0
    Other meat‡  9 (12)  1 (11)  7 (78)  1 (11)  9 (100)  0 0
    Other food§  20 (27)  6 (30)  8 (40)  6 (30)  20 (100)  0 0
Total 844 (100)  300 (36)  366 (43)  178 (21)  691 (82)  139 (16)  14 (2) 
*UTI, urinary tract infection. 
†British Columbia (n = 4) and Saskatchewan (n = 10). 
‡Bison, lamb, duck, and snail.  
§Fruits (honeydew melon), vegetables, cheese, rice, couscous, and pasta. RESEARCH
infections) tend to be more similar to antimicrobial-resis-
tant and -susceptible E. coli from retail poultry meat sourc-
es (14,15). These observations indicate that the selection of 
resistant E. coli is more likely to occur in the animal food 
reservoir than in humans. In this study, we observed that 
genetically related E. coli from food sources and human 
infections tended to be susceptible, suggesting that both 
resistant and susceptible isolates causing UTIs in women 
may be transmitted through the food supply. Our study also 
identiﬁ  ed members of the O2:H7-ST95 group, previously 
associated with extraintestinal disease in both humans and 
avian hosts (34). The O2:H7-ST95 food source isolate from 
this study was from a honeydew melon. Potential origins 
of this E. coli contamination could include human or food 
animal sources.
The E. coli O25:H4-ST131 clonal group, also identiﬁ  ed 
in this study, has been associated with extended spectrum 
β-lactamase production and ﬂ  uoroquinolone resistance and 
has been found across Europe and in Canada (18,35–37). 
The E. coli O25:H4-ST131 isolates identiﬁ  ed in this study 
are susceptible; however, because this clonal group may 
be found in a food animal reservoir and transmitted by 
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Table 2. Characteristics of Escherichia coli clonal groups identified within isolates from 3 types of samples, Canada, 2005–2007*†
Genotype
Group and strain
Type of 
sample
Isolate
source Location‡ Year MLVA ERIC2 XbaI PFGE
MLST
ST Serotype
1
 EC01DT06-1737-01 Retail meat Chicken Montreal 2006 1.033 33.01 33A.0 131 O25:H4
 MSHS  161 Clinical Human Montreal 2005 1.033 33.01 33A.0 131 O25:H4
 MSHS  1134A Clinical Human Montreal 2007 1.033 33.01 33A.1 131 O25:H4
2
 68616.01 RTE Honeydew Montreal 2005 1.018 18.01 18A.0 95 O2:H7
 MSHS  100 Clinical Human Montreal 2005 1.018 18.01 18A.0 95 O2:H7
 MSHS  186 Clinical Human Montreal 2005 1.018 18.01 18A.0 95 O2:H7
 MSHS  811 Clinical Human Montreal 2006 1.018 18.01 18A.0 95 O2:H7
 MSHS  1229 Clinical Human Montreal 2007 1.018 18.01 18A.1 95 O2:H7
 MSHS  95 Clinical Human Montreal 2005 1.018 18.01 18A.2 95 O2:H7
 MSHS  1062 Clinical Human Montreal 2007 1.018 18.01 18A.2 95 O2:NM
 MSHS  782 Clinical Human Montreal 2006 1.018 18.01 18A.4 95 O2:H7
 MSHS  819 Clinical Human Montreal 2006 1.018 18.01 18A.4 95 O2:H7
3
 EC01DT05-0789-01 Retail meat Chicken Ontario 2005 1.023 23.01 23A.0 117 O114:H4
 MSHS  1014A Clinical Human Montreal 2007 1.023 23.01 23A.5 117 O114:H4
 EC01DT05-0224-01 Retail meat Chicken Ontario 2005 1.023 23.01 23B 117 ONT:NM
 EC01DT06-1887-01 Retail meat Chicken Montreal 2006 1.023 23.01 23C 117 O143:H4
 EC01DT07-0956-01 Retail meat Chicken Other 2007 1.023 23.01 23D 117 O53:H4
 EC01DT05-1700-01 Retail meat Chicken Quebec 2005 1.023 23.01 NT 117 O160:H4
 EC01DT07-1050-01 Retail meat Chicken Ontario 2007 1.023 23.01 NT 117 O45:H4
 EC01DT07-1090-01 Retail meat Chicken Montreal 2007 1.023 23.01 NT 117 O24:H4
 MSHS  133 Clinical Human Montreal 2005 1.023 23.01 NT 117 O24:NM
4
 EC01DT06-0649-01 Retail  meat Pork Montreal 2006 1.116 116.01 116A 69 O17/73/106:H18
 MSHS  719 Clinical Human Montreal 2006 1.116 116.01 116C 69 O44:H18
 MSHS  956 Clinical Human Montreal 2007 1.116 116.01 116D 69 ONT:H18
5
 EC01DT05-1012-01 Retail meat Pork Ontario 2005 1.102 102.01 102A 493 O4:H5
 MSHS  769 Clinical Human Montreal 2006 1.102 102.01 102B 493 O4:H5
6
 EC01DT06-1265-01 Retail meat Beef Montreal 2006 2.107 107.01 107A 401 O36:NM
 76083.08 RTE Chicken Montreal 2007 2.107 107.01 107B 401 O36:NM
7
 EC01DT06-0274-01 Retail meat Chicken Quebec 2006 2.097 97.01 97A 295 O172:H16
 79287 RTE Chicken Montreal 2007 2.097 97.01 97B 295 O172:H16
*MLST, multilocus sequence typing; MLVA, multilocus variable number tandem repeat analysis; ERIC2, enterobacterial repetitive intergenic consensus 
sequence 2; PFGE, pulsed-field gel electrophoresis; ST, sequence type; RTE, restaurant/ready-to-eat foods; NT, nontypeable; ONT, serogroup 
nontypeable; NM, non-motile; UNK, unknown. An expanded version of Table 2 containing all isolates is available online at 
www.cdc.gov/EID/content/16/1/88-T2.htm. 
†All isolates in groups 1, 2, and 5 were phylotype B2; all isolates in groups 3, 4, and 8 were phylotype D; all isolates in groups 6, 9, 10, and 11, as well as 
isolate MSHS 689 in group 17, were phylotype A; all isolates in groups 7, 12, 13, 14, 15, and 16, as well as isolate EC01DT05-0469-01 from group 17, 
were phylotype B1. 
‡Other locations were Saskatchewan or British Columbia. Food Reservoir for E. coli Causing UTI
food, ampliﬁ  cation and transmission of these highly re-
sistant organisms could be possible. Extended spectrum 
β-lactamase-producing E. coli have not yet been identiﬁ  ed 
by CIPARS (23,38,39).
This study was ecologic in design and presents several 
limitations. Epidemiologic information on the UTI cases was 
not available. Information on travel, history of antimicrobial 
drug use, dietary information, and other factors would have 
been useful to describe the study population and to assess the 
signiﬁ  cance of other possible transmission routes that might 
explain our results. The study also oversampled retail chick-
en meat and consequently undersampled isolates from retail 
pork and beef. It is possible that closely related clonal groups 
could be identiﬁ  ed that contain isolates from both human in-
fections and pork or beef samples. Because of insufﬁ  cient 
power in our sampling strategy we could not exclude the ex-
istence of these groups; additional sampling of isolates from 
retail pork and beef are underway to address this question. 
Despite oversampling isolates from retail chicken meat, we 
observed that 82% (a greater fraction than the 60% sampling 
fraction) of E. coli belonging to the 17 clonal groups were 
associated with retail chicken meat. We also oversampled 
antimicrobial drug-resistant isolates; however, most (53%) 
isolates that belonged to a clonal group were fully suscepti-
ble. Even though the size and scope of this study was limited, 
we were able to detect several instances of groups containing 
closely related isolates from human and food sources. It is 
therefore probable that a food reservoir exists and that food-
borne transmission of extraintestinal E. coli is common.
The identiﬁ  cation of 2 clonal groups containing isolates 
from retail chicken meat and human infections supports our 
a priori hypothesis. We cannot exclude the possibility that 
food source isolates were present because of human con-
tamination during food production, processing or handling, 
even though it is very unlikely. Subsequent research will 
help determine whether these E. coli occur in a food animal 
reservoir or whether transfer of these E. coli results from 
contamination during food processing or preparation and 
reﬂ  ects human-to-human transmission by food.
This study demonstrates that some E. coli from retail 
chicken meat and other food sources are closely related to 
E. coli causing human UTIs. Since a food animal reser-
voir apparently exists for E. coli that cause urinary tract 
and other extraintestinal infections, this further reinforces 
the need for responsible antimicrobial drug stewardship in 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 1, January 2010  93 
Figure 1. Pulsed-ﬁ  eld gel electrophoresis patterns for Escherichia 
coli O2:H7-ST95 and E. coli O25:H4-ST131. A) XbaI; B) NotI. Lane 
1 is the positive control E. coli O11:H18-ST69 (SEQ102); lane 2 is an 
E. coli O2:H7-ST95 isolate from a restaurant sample of honeydew 
melon (68616.01); lanes 3–10 are isolates from human urinary tract 
infection cases (UTIs; lane 3, MSHS 100; lane 4, MSHS 186; lane 
5, MSHS 811; lane 6, MSHS 1229; lane 7, MSHS 95; lane 8, MSHS 
1062; lane 9, MSHS 782; lane 10, MSHS 819); lane 11 is an E. coli 
O25:H4-ST131 isolate from a retail chicken sample (EC01DT06-
1737-01); and lanes 12 and 13 are E. coli isolates from human 
UTIs (lane 12, MSHS 161; lane 13, MSHS 1134A). Outer lanes are 
pulsed-ﬁ  eld molecular weight markers. 
1 3 2
XbaI NotI
1 3 2
Figure 2. XbaI and NotI pulsed-ﬁ  eld gel electrophoresis patterns 
for Escherichia coli O114:H4-ST117 (lanes 2 and 3). Lane 1 is the 
positive control E. coli O11:H18-ST69 (SEQ102), lane 2 is an E. coli 
O25:H4-ST131 isolate from a retail chicken sample (EC01DT06-
1737-01), and lane 3 is an E. coli isolate from a human urinary tract 
infection case (MSHS 1014A). Outer and center lanes are pulsed-
ﬁ  eld molecular weight markers.RESEARCH
veterinary medicine and food animal production as well as 
in human medicine.  
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